非病毒脂质纳米颗粒 RNA 输送系统

GenVoy-ILM™ 是一种可电离脂质混合物,使装载 RNA 的 脂质纳米颗粒 (LNP) 能够用  NanoAssemblr™ 平台方便快捷地制备。GenVoy-ILM 是开始使用脂质纳米颗粒时最简单的方式,也是最先进的非病毒核酸输送技术。


  • • 包封效果出色
  • • 毒性低
  • • 基因输送效力高




Endogenous Uptake



Screen Shot 2019-06-21 at 2.58.04 PM

Deliver siRNA for sustained gene knockdown

A single injection of GenVoy-ILM Luciferase mRNA-LNP was administered to mice via the tail vein at an RNA dose of 1 mg/mL. Luciferase expression was measured by 6-hours post-mRNA-LNP administration.



Deliver mRNA for gene expression

A single injection of GenVoy-ILM Factor VII siRNA-LNP was administered to mice via the tail vein at the RNA doses indicated and plasma levels of Factor VII protein were measured up to 21 days post-administration.
Asset 1

Lipid Nanoparticles

LNPs contain a pH-sensitive ionizable cationic lipid that attract anionic nucleic acids to form the core of self-assembling nanoparticle to ensure high encapsulation.


At physiological pH, LNPs are neutral, eliminating a mechanism of toxicity seen with permanently cationic molecules.


These same pH-sensitive lipids are responsible for responding to the acidic environment of the endosome and triggering the disruption of the endosome and release of the nucleic acid into the cell.

Nucleic Acid Lipid Nanoparticle

Both The Chemistry And The Process Determine The Outcome


LNPs made with the NanoAssemblr®Platform have a unique homogeneous structure that is more effective compared to other methods of manufacture such as T-tube mixing. 

NanoAssemblr v Conventional T-tube
LNPs made with NanoAssemblr® Technology and containing siRNA against Factor VII results in more effective in vivo gene knockdown than those made with a T-junction. Lower bars indicate more effective knockdown of Factor VII measured in serum of mice treated intravenously with the indicated dose of siRNA.

Product Information

GenVoy-ILM is a pre-blended lipid mix in ethanol and is available in two formats with or without added dye for visualization.


• 2 mL

• 5 mL

GenVoy-ILM Vials

The Chemistry And The Process Affect The Outcome 

LNPs made with the NanoAssemblr platform exhibit a unique homogeneous core structure with exceptionally consistent size within and between batches, which has been shown to be more potent than particles made by other methods. 



Screen Shot 2019-06-13 at 4.30.52 PM



Use Genvoy-ILM for: 

  • • Gene silencing 
  • • Gene expression 
  • • Gene editing 
  • • Gene modulation 

Use GenVoy-ILM to encapsulate and deliver RNA: 

  • • siRNA 
  • • miRNA 
  • • tRNA 
  • • gRNA 
  • • mRNA 


欲了解 Precision NanoSystems 如何加速从创意到临床应用的纳米药物研发过程,请联系我们的技术销售团队。



Publication - Summary

September 24, 2017

Nano Letters

Boosting Intracellular Delivery of Lipid Nanoparticle-Encapsulated mRNA

Patel, A., Ashwanikumar, N., Robinson, E., DuRoss, A., Sun, C., Murphy-Benenato, K. E., Mihai, C., Almarsson, Ö., Sahay...

Read More 阅读更多

Publication - Abstract

March 19, 2018

Advanced Drug Delivery Reviews

Advances in Microfluidics for Lipid Nanoparticles and Extracellular Vesicles and Applications in Drug Delivery Systems

M. Maekia, N. Kimurab,Y. Satoc, H. Harashimac, M. Tokeshi

Read More 阅读更多


August 16, 2017

Lipid Nanoparticles to Deliver Nucleic Acids in Neuroscience Research - Peter Johnson, PNI

Read More 阅读更多

Publication - Abstract

January 15, 2016

Therapeutic Delivery

siRNA Delivery: Current Trends and Future Perspectives

Singh, Manu Smriti, and Dan Peer

Read More 阅读更多


July 28, 2016

NanoAssemblr® GMP Scale-Up System | Ray Lockard, Precision NanoSystems

Read More 阅读更多

Publication - Summary

December 16, 2016

Angewandte Chemie International Edition

Non-Viral CRISPR/Cas Gene Editing In Vitro and In Vivo Enabled by Synthetic Nanoparticle Co-Delivery of Cas9 mRNA and sgRNA

Miller JB, Zhang S, Kos P, Xiong H, Zhou K, Perelman SS, Zhu H, Siegwart DJ

Read More 阅读更多
Resource Center 资源中心


立即注册,以便自动接收最新 Precision NanoSystems 应用说明、会议海报、相关科技出版物和网络研讨会邀请函。